Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2011
06/30/2011US20110159485 Lysis Buffers for Extracting Nucleic Acids
06/30/2011US20110159484 Apparatus and method of authenticating product using polynucleotides
06/30/2011US20110159483 Cyanine compounds, compositions including these compounds and their use in cell analysis
06/30/2011US20110159482 Method for detecting multiple small nucleic acids
06/30/2011US20110159481 Solid-phase chelators and electronic biosensors
06/30/2011US20110159480 Cell-based screening assay to identify molecules that stimulate ifn-alpha/beta target genes
06/30/2011US20110159479 Genetic polymorphisms in the cytochrome p450 gene with clopidogrel resistance
06/30/2011US20110159478 Method for screening drug candidates by using domain protein
06/30/2011US20110159477 Products and analytical method
06/30/2011US20110159476 Methods and apparatus for characterizing polymeric mixtures
06/30/2011US20110159168 Non-transgenic Tomato Varieties Having Increased Shelf Life Post-Harvest Due to Alterations in Beta-Galactosidase 4
06/30/2011US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels
06/30/2011US20110159121 Methods and compositions for identifying, producing and using plant-derived products for modulating cell function and aging
06/30/2011US20110159043 Allogeneic vaccine and methods to synthesize same
06/30/2011US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection
06/30/2011US20110159040 Novel immunogens and methods for discovery and screening thereof
06/30/2011US20110159025 Methods, agents and peptides for inducing an innate immune response in HIV vaccination
06/30/2011US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine
06/30/2011US20110159021 Xbp1, cd138, and cs1 peptides
06/30/2011US20110159020 Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof
06/30/2011US20110159017 Trytophan catabolism in cancer treatment and diagnosis
06/30/2011US20110159012 Method for isolating neural cells using tenascin-r compounds
06/30/2011US20110159011 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
06/30/2011US20110158997 Single chain fragment variable antibody libraries and uses thereof
06/30/2011US20110158984 Anti-orthopoxvirus recombinant polyclonal antibody
06/30/2011US20110158980 Methods to treat and screen for agents to treat obesity
06/30/2011US20110158979 Genetic component of complications in type 2 diabetes
06/30/2011US20110158966 Stem cells characterized by expression of germline specific genes
06/30/2011US20110158959 Immunophenotype and immunogenicity of human adipose derived cells
06/30/2011US20110158953 Tumor suppression through plexin c1
06/30/2011US20110158952 Compositions and methods for treating human papillomavirus-mediated disease
06/30/2011US20110158951 Use of blood group status ii
06/30/2011US20110158950 Use of blood group status i
06/30/2011US20110158947 Sulfonylurea receptor and means for treating ischaemia
06/30/2011US20110158944 Braf biomarkers
06/30/2011US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
06/30/2011US20110158939 Methods and Compositions for Treating Asthma in Human and Nonhuman Primates
06/30/2011US20110158911 Methods for Screening for Antibiotic Compounds
06/30/2011US20110158908 Cyclosporin a-binding protein
06/30/2011US20110155586 Nanogap chemical and biochemical sensors
06/30/2011DE112009001722T5 Verfahren zur Diagnose von Legasthenie A method for diagnosing dyslexia
06/30/2011DE102010049607A1 Konjugate von Nukleotiden und Methoden zu deren Anwendung Conjugates of nucleotides and methods for their application
06/30/2011DE102009060836A1 Anschmutzung Soiling
06/30/2011DE102009041254A1 Spontan kontrahierende Fischzellaggregate, deren Verwendung und Verfahren zu deren Erzeugung Spontaneously contracting fish cell aggregates, their use and process for their production
06/30/2011CA2822747A1 Methods and compositions for cardiovascular diseases and conditions
06/30/2011CA2817990A1 Methods of enriching and detecting fetal nucleic acids
06/30/2011CA2784781A1 Predictive value of il28b gene polymorphism combined with pretreatment serum ip-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any ofthese biomarkers alone
06/30/2011CA2784425A1 Differentiation of human embryonic stem cells
06/30/2011CA2784415A1 Differentiation of human embryonic stem cells
06/30/2011CA2784344A1 Tsg primer target detection
06/30/2011CA2782300A1 Gene dro1 controlling deep-rooted characteristics of plant and utilization of same
06/30/2011CA2775074A1 Reactor for bulk manufacture of pcr amplicons
06/29/2011EP2339350A1 Arrays
06/29/2011EP2339348A2 Method for diagnosing neuro-degenerative disease
06/29/2011EP2339347A1 Method of identifying transmembrane protein-interacting compounds
06/29/2011EP2339326A1 Automatic threshold setting and baseline determination for real-time PCR
06/29/2011EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer
06/29/2011EP2339034A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
06/29/2011EP2339033A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
06/29/2011EP2339032A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
06/29/2011EP2339031A1 Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field
06/29/2011EP2339030A1 Screening method for liver x receptor agonists and application thereof
06/29/2011EP2339029A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
06/29/2011EP2339028A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
06/29/2011EP2339027A2 Immunoaffinity isolation of modified peptides from complex mixtures
06/29/2011EP2339026A1 Method for simultaneously detecting histoplasma capsulatum and paracoccidioides brasiliensis
06/29/2011EP2339025A1 Methods and compositions for determining methylation profiles
06/29/2011EP2339024A1 Methods for quantitative determination of methylation density in a DNA locus
06/29/2011EP2339023A2 Detection of mycobacteria and their resistant genes
06/29/2011EP2339022A2 Use of methylated or unmethylated line-1 DNA as a cancer marker
06/29/2011EP2339021A1 Activated partial thromboplastin time measuring reagent, activated partial thromboplastin time measuring method, and determination method for determining presence or absence of blood coagulation inhibitor
06/29/2011EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A)
06/29/2011EP2339018A2 Staining process and apparatus used in bacteriology
06/29/2011EP2338989A1 Method for preparing fecal sample, fecal sample preparation solution, and feces collection kit
06/29/2011EP2338988A1 Evaluation/screening method for diseases associated with d-amino acid utilizing dao1-/- mouse
06/29/2011EP2338978A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
06/29/2011EP2338913A1 Chromosome 13-linked breast cancer susceptibility gene
06/29/2011EP2338906A1 Compostion and methods for increasing bone mineralization
06/29/2011EP2338901A1 Replikin peptides and uses thereof
06/29/2011EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
06/29/2011EP2338896A2 Use of lignin peroxidase in skin and hair lightening
06/29/2011EP2338893A1 Labelled nucleotides
06/29/2011EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell
06/29/2011EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
06/29/2011EP2338507A1 Method of treating malignancies through induction of blood immune responses
06/29/2011EP2338505A2 Vault and vault-like carrier molecules
06/29/2011EP2338504A2 Vault and vault-like carrier molecules
06/29/2011EP2337868A1 Detection of granulosa-cell tumors
06/29/2011EP2337867A1 Detection of npm1 nucleic acid in acellular body fluids
06/29/2011EP2337865A1 Improved allele-specific amplification
06/29/2011EP2337864A2 Biomarkers for predicting the development of chronic autoimmune diseases
06/29/2011EP2337863A1 Diagnostic markers for ankylosing spondylitis
06/29/2011EP2337862A2 Biomarkers for insulin efficacy
06/29/2011EP2337860A1 Oligonucleotide detection method
06/29/2011EP2337859A1 Compositions and methods for the rapid growth and detection of microorganisms
06/29/2011EP2337858A1 Cationic polymer based wired enzyme formulations for use in analyte sensors
06/29/2011EP2337850A2 Anti-protozoa compounds
06/29/2011EP2155896B1 Method of testing for atp load in commercial laundry and for data tracking the results
06/29/2011EP2082057B1 Detection of proteases
06/29/2011EP2021513B1 Compositions and methods to detect enterococci nucleic acid